← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2006Last known activity
Feb 28, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05699005CollaboratorPhase 1Feb 28, 2023
- NCT04748796CollaboratorN/AFeb 1, 2021
- NCT04589546CollaboratorPhase 3Oct 31, 2020
- NCT02302469Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2009
- NCT00832234CollaboratorPhase 2Sep 1, 2006
Details
- Last known activity
- Feb 28, 2023